Early Interim Negative FDG-PET/CT Is a High Predictive Factor for Progression-Free Survival in Hodgkin Lymphoma.
Eldad J. Dann(Rambam Health Care Campus), Ron Epelbaum(University of Bern), Menachem Ben‐Shachar(Rambam Health Care Campus), Nissim Haim(Technion – Israel Institute of Technology), Jacob M. Rowe(Technion – Israel Institute of Technology), Irit Avivi(Tel Aviv Sourasky Medical Center), Diana Gaitini(Technion – Israel Institute of Technology), Ora Israel(Technion – Israel Institute of Technology), Ada Tamir(Technion – Israel Institute of Technology), Rachel Bar‐Shalom(Rambam Health Care Campus)
Cited by 0
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907